Navigation Links
Micromet Presents Update on Blinatumomab's Response Rate and Duration in a Phase 1 Study in Non-Hodgkin's Lymphoma Patients
Date:6/8/2009

ical trials. Its BiTE antibody blinatumomab (MT103) is in a phase 2 clinical trial for the treatment of patients with acute lymphoblastic leukemia (ALL), and in a phase 1 clinical trial for the treatment of patients with non-Hodgkin's lymphoma (NHL). A second BiTE antibody, MT110, is in a phase 1 clinical trial for the treatment of patients with solid tumors. MT110 binds to the epithelial cell adhesion molecule, or EpCAM, which is overexpressed in many solid tumors. Micromet's human monoclonal antibody adecatumumab (MT201) also binds to EpCAM and is being developed under a collaboration with Merck Serono. Adecatumomab is in a phase 2 clinical trial in colorectal carcinoma patients after complete resection of liver metastases, and a phase 1b clinical trial evaluating adecatumumab in combination with docetaxel for the treatment of patients with metastatic breast cancer. Micromet's monoclonal antibody MT293, also known as TRC093, is licensed to TRACON Pharmaceuticals, Inc., and is in a phase 1 clinical trial for the treatment of patients with cancer.

In addition, Micromet has established a collaboration with Nycomed for the development and commercialization of MT203, a human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of various inflammatory and autoimmune diseases, such as rheumatoid arthritis, psoriasis, or multiple sclerosis. Nycomed has filed a clinical trial application and is expected to commence a phase 1 clinical trial of MT203 in the first half of 2009. Micromet's licensee Morphotek, a wholly-owned subsidiary of Eisai, is also expected to initiate a first phase 1 clinical trial with Micromet's glycolipid-binding human antibody MT228 for the treatment of melanoma. Micromet also has entered into an option, collaboration and license agreement with Bayer Schering Pharma AG under which Bayer Schering Pharma was granted an exclusive option to licen
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day
2. Micromet Presents Preclinical Data Showing Activity of Erbitux and Vectibix Based BiTE Antibodies against KRAS- and BRAF-mutated Human Colorectal Cancer Cells
3. Micromet Receives Milestone Payment for Filing of the First Clinical Trial Application for MT203
4. Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients
5. Micromet Key Events for 2009
6. Micromet Expands Committed Equity Financing Facility to $75 Million
7. Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells
8. Micromet Presents Data at ESMO 2008 on Anti-EpCAM Antibody Adecatumumab (MT201) in Combination with Chemotherapy
9. Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE
10. Micromet, Inc. to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results
11. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014 Soligenix, ... late-stage biopharmaceutical company developing products that address unmet ... and biodefense, announced today that on December 24, ... offering. The Company raised approximately $2.3 ... intends to use the net proceeds from the ...
(Date:12/24/2014)... and LONDON , December 24, ... industry are expected to grow at an average rate ... of value and volume. Hip, knee and spine surgeries ... while in emerging economies they have a lower penetration. ... challenging the use of composites. Non-metallic orthopedic devices have ...
(Date:12/24/2014)... DALLAS , December 24, 2014 /PRNewswire/ ... Research Report on Global Disposable Syringe Industry ... to its online business intelligence library. ... Global Disposable Syringe Industry is a professional ... Syringe market.  For overview analysis, the report ...
Breaking Medicine Technology:Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5
... SPRINGS, Fla., Oct. 8 The most comprehensive, ... and regulations is now available from Point of ... information technology (HIT) strategy and management consulting firm ... health records, health information exchanges and personal health ...
... Millennium Research Group (MRG), the global authority on medical ... surgical lights will represent 100% of surgical light sales ... longer lasting LED lights. MRG,s European Markets for ... report finds that adoption will be accelerated in Europe, ...
Cached Medicine Technology:Newly Updated Pharmacy State Law Compendium Available 2LEDs To Completely Replace Halogen Lights in the European Surgical Market By 2014 2LEDs To Completely Replace Halogen Lights in the European Surgical Market By 2014 3
(Date:12/24/2014)... Dennis Thompson HealthDay Reporter ... news about the experimental Ebola vaccine that U.S. officials are ... shows a precursor of that vaccine produced a safe and ... the vaccine, when given to more than 100 Ugandans in ... blood cells that could potentially protect a person against infection ...
(Date:12/24/2014)... -- Longer and colder body cooling does not reduce the ... a lack of oxygen, a new study finds. The ... -- called hypoxic ischemic encephalopathy -- can be reduced by ... for 72 hours, experts say. Research has shown that ... this study examined if the same would be true in ...
(Date:12/24/2014)... News) -- Though most patients with obsessive-compulsive disorder (OCD) ... 10 percent to 20 percent have a form of ... say. However, patients with this so-called "refractory OCD" ... of brain surgery that disables certain brain networks believed ... between patients most likely to benefit from the surgery, ...
(Date:12/24/2014)... TUESDAY, Dec. 23, 2014 (HealthDay News) -- If you ... off if you are not treated by a cardiologist, ... actually improved when cardiologists left town for annual professional ... with cardiac arrest who were admitted to a teaching ... days, but 70 percent died when these meetings were ...
(Date:12/22/2014)... December 22, 2014 As part ... senior care service in San Diego and ... of its senior care team with ongoing online ... Golden Care is provided by Caregiverlist®. Caregiverlist® ... caregivers with the most reliable eldercare options, highest ...
Breaking Medicine News(10 mins):Health News:Early Study Offers Hope for an Ebola Vaccine 2Health News:Early Study Offers Hope for an Ebola Vaccine 3Health News:Early Study Offers Hope for an Ebola Vaccine 4Health News:Greater Cooling of Oxygen-Deprived Infants Fails to Improve Survival 2Health News:Scans May Spot People Who'll Benefit From Surgery for OCD 2Health News:When Heart Docs Are Away, Their High-Risk Patients May Fare Better 2Health News:When Heart Docs Are Away, Their High-Risk Patients May Fare Better 3Health News:Golden Care Partners with Nationally Recognized Caregiver Training Service 2
... The Madras Institute of Trauma (MIOT) deserves to be called ... minimally invasive surgery (MIS) for all kinds of surgeries. // ... that provides 40 fold magnification of a specific body ... liver, cardiac bypass, surgical excision of brain tumor, spinal injury ...
... cell research in the state with the approval of 61% ... have impeded the initiative. // ,The officials now ... will be initiated. Zach Hall, president of the California Institute ... would commence the project as soon as possible. ...
... head of Psycho and Geriatrics Ward at the Punjab Institute of ... their relatives after they have been declared mentally fit by doctors. ... such patients who have completely recovered but no place to go. ... members they say that these patients are of no use and ...
... rushing off at lunch breaks, coughing up ?4,500 for Jiffy ... for such breast implant operations//, and is getting into the ... Kirkham was one of the first to be on their ... by her mom and a student loan. She said: ...
... buster, pain reliever, sleep-inducer, hair conditioner and wrinkle remover, ... guessing! Intimate sex with your partner can provide the much ... NHS helpline says "Forget about jogging round the block or ... fact, good bout of 'sexercise'." ,The NHS site ...
... has spent the last two decades in chains in a ... Pradesh//. His family said that Mansharam did not move at ... ,His brother Bhogchand says that Mansharam was chained to a ... "We spent a lot of money to get him treated ...
Cached Medicine News:Health News:Any Form Of Minimally Invasive Surgery- Name It & They Do It! 2Health News:Momentum of Stem cell research impeded by legal challenges 2Health News:Is mental illness a social stigma? 2
... pacemaker family, which includes the world's ... the most advanced pacemaker technology available, ... the first and only U.S. commercially ... fibrillation (AF). The AF Suppression algorithm ...
... the real-time monitoring surveillance of a ... tools. Moreover, the Information Center is ... so that monitoring data can be ... radiology images, archived data, lab results, ...
... system uses catheters that are controlled ... console. The console processes the refrigerant, ... tip of the catheter, creates cryogenic ... an easy-to-use touch-screen interface. From this ...
... tasks and delivers consistently reliable ... and ensure testing accuracy in ... automated reticulocyte counts and three-dimensional ... sensitivity, specificity and efficiency in ...
Medicine Products: